Yahoo Search Búsqueda en la Web

  1. Anuncio

    relacionado con: Jim Allison
  2. No matter what you love, you'll find it here. Search Jim Allison and more. Fast and Free Shipping on many items you love on eBay.

Resultado de búsqueda

  1. Doctoral advisor. Barrie Kitto. James Patrick Allison (born August 7, 1948) [4] is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas .

    • Barrie Kitto
  2. 1 de oct. de 2018 · 1 octubre 2018. Getty Images. El estadounidense James P. Allison y el japonés Tasuku Honjo descubrieron cómo usar nuestras células para combatir el cáncer. Los inmunólogos James P. Allison...

  3. James P. Allison. Facts. © Nobel Media AB. Photo: A. Mahmoud. James P. Allison. The Nobel Prize in Physiology or Medicine 2018. Born: 7 August 1948, Alice, TX, USA. Affiliation at the time of the award: Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; University of Texas MD Anderson Cancer Center, Houston, TX, USA.

  4. 22 de oct. de 2018 · Jim Allison is an iconoclastic scientist who toiled in obscurity for years. Then he helped crack a mystery that may save millions of lives: Why doesn’t the immune system attack cancer? Scott...

  5. 1 de oct. de 2018 · James P. Allison studied a known protein that functions as a brake on the immune system. He realized the potential of releasing the brake and thereby unleashing our immune cells to attack tumors. He then developed this concept into a brand new approach for treating patients.

  6. 1 de oct. de 2018 · James Allison at the University of Texas MD Anderson Cancer Center in Houston and Tasuku Honjo at Kyoto University in Japan will share the 9 million Swedish kronor (US$1 million) prize. The...

    • Heidi Ledford, Holly Else, Matthew Warren
    • 2018
  7. James P. Allison. Biographical. As a basic scientist, I have been fortunate to see my research findings translate into a powerful new potentially curative treatment strategy for cancer. The first patient I met was Sharon Belvin. I met her in 2006 at Memorial Sloan-Kettering Cancer Center (MSKCC).